â– LECTURE OVERVIEW: Neonatal Jaundice (hyperbilirubinemia) is a common clinical finding, classified chronologically into physiological and pathological profiles.
â– THE DYNAMIC SPLITS:
1. Physiological Jaundice (Normal/Benign):
- Pathogenesis: Caused by a transient, relative deficiency of hepatic UDP-glucuronosyltransferase (UGT) activity in a neonate with high red cell turnover.
- Timeline: Arises after the first 24 hours of life, peaking on days 3-5 before resolving.
2. Pathological Jaundice (Diseased):
- Pathogenesis: Driven by hemolysis (e.g., Rh/ABO incompatibility), biliary atresia, or sepsis.
- Timeline: Begins within the first 24 hours of life. Bilirubin levels rise quickly (>5 mg/dL/day or >15 mg/dL total).
â– CLINICAL DIAGNOSTIC METRICS:
Establishing a definitive diagnosis requires combining serum biomarkers with gold-standard diagnostic modalities. High-sensitivity ELISAs are used initially to minimize false negatives, followed by highly specific confirmatory testing.
â– EMERGENCY DECREES & FAST-TRACK RESPONSES:
Upon presentation with extreme physiological disruption, initiate immediate volume restoration and broad-spectrum metabolic stabilization.
[HY-BOARD-1242]
🌟 Dynamic Clinical Key:
In pathological jaundice, high levels of unconjugated (indirect) bilirubin can cross the blood-brain barrier. Bilirubin deposits selectively in the basal ganglia, predisposing the neonate to acute bilirubin encephalopathy or permanent, devastating Kernicterus. Always correlate elevated serum spikes with continuous vital readings to rule out false laboratory spikes. Confirm central vital markers continually rather than relying solely on peripheral readings.